![David Bredt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Bredt
Gründer bei
RAPPORT THERAPEUTICS, INC.
Vermögen: 16 Mio $ am 31.05.2026
Profil
David Bredt founded Rapport Therapeutics, Inc. in 2022, where he is working as Chief Scientific Officer from 2024.
Dr. Bredt also currently works at CONNECT, as Director.
Dr. Bredt also formerly worked at Eli Lilly & Co., as Vice President-Neuroscience from 2004 to 2011, MPM BioImpact LLC, as Partner in 2021, and Janssen Global Services LLC, as Global Head-Neuroscience Discovery from 2011 to 2021.
Dr. Bredt received his undergraduate degree from Princeton University and doctorate degree from The Johns Hopkins University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.02.2026 | 393’075 ( 0.82% ) | 16 Mio $ | 31.05.2026 |
Aktive Positionen von David Bredt
| Unternehmen | Position | Beginn |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Gründer | 01.02.2022 |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Bredt
| Unternehmen | Position | Ende |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Corporate Officer/Principal | 02.08.2021 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Corporate Officer/Principal | 01.03.2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von David Bredt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Develops treatments for patients in therapeutic areas of healthcare | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
